Sponsors

Disease map

French genomics company IntegraGen has discovered a groundbreaking method of identifying causal disease genes, with the aid of Applied BiosystemsÆ custom assays and the SNPIex genotyping system.

Its gene-mapping technology û genome hybrid identity profiling (GenomeHIP) û works on the assumption that the same disease genes will be found in related individuals with the same disease, so the disease loci can be mapped by removing non-identical DNA sequences the genomes share. J÷rg Hager, IntegraGenÆs chief scientific officer, explained how Applied BiosystemsÆ products have helped: ôFor any disease in a given population, we identify up to seven potential disease loci, assemble a panel of region-specific SNPs and have assays manufactured by Applied Biosystems. Within a couple of days we can use the assays to analyse a large number of individuals using the SNPIex Genotyping System.ö

Latest Issues

Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
7 April, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026

39th International Symposium on Technical Innovations in Laboratory Hematology

Edinburgh International Convention Centre
17-19 April, 2026

ESCMID Global 2026

Messe München Munich, Germany
17-21 April, 2026